Oncoinvent Expands Phase 2 Radspherin Trial with New Sites and First Patient Enrollment

2 hours ago

Claim 50% Off TipRanks Premium• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions • Stay ahead of the market with …

Read Entire Article

Oncoinvent Expands Phase 2 Radspherin Trial with New Sites and First Patient Enrollment

Related

Wisdomtree Expands Tokenized Funds to Solana, Boosting RWA A...

Biggest risk in AI investing? 'Project cost blowouts', says ...

Exchange rate strengthens to N1,394/$1, highest since May 20...

What Tech Wants: Crypto Reign Of Terror

Hang Seng launches physical gold ETF with tokenization optio...

Ethereum loses $3K again: How low can ETH price go in Februa...

Coordinated Yen Intervention More Sugar Hit Than Long-Term F...

Abu Dhabi company launches first UAE-registered US dollar st...

Popular

Stock Market Today, Jan. 28: S&P 500 tops 7,000 for the firs...

Govt shutdown threat — what it means for Bitcoin

Trump Reveals Best Investments Now

Supply Squeeze: Bitcoin Reclaims $90,000 as Binance Inflows ...

Flare Positions FXRP as XRP’s Asset of Choice on Hyperliquid...

Will the fed cut rates by 75 BPS in 2026?